Latest News about NUVL
Recent news which mentions NUVL
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 28, 2022
From Benzinga
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday
August 01, 2022
From Benzinga
From Benzinga
From Benzinga
Nuvalent Highlights New Data Exhibiting Expanded Preclinical Activity Of NVL-520 In ROS1-Driven Cancers
April 11, 2022
Tickers
NUVL
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
March 17, 2022
From Benzinga
96 Biggest Movers From Yesterday
March 15, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 19, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
January 07, 2022
From Benzinga
58 Biggest Movers From Yesterday
January 07, 2022
From Benzinga
65 Biggest Movers From Yesterday
December 21, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 26, 2021
From Benzinga
80 Biggest Movers From Yesterday
November 17, 2021
From Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
From Benzinga
36 Biggest Movers From Yesterday
October 06, 2021
From Benzinga
50 Biggest Movers From Yesterday
September 23, 2021
From Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
From Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
From Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
From Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2021
August 23, 2021
From Benzinga
The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More
August 22, 2021
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 16, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.